NovoCure files Form 8-K
NovoCure filed a Form 8-K on October 29.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
NOV files Form 8-K
NOV filed a Form 8-K on October 28.
Nova Minerals files Form 8-K
Nova Minerals Corp filed a Form 8-K on October 27.
F N B Q3 2026 Earnings Call Transcript
F N B (NYSE: FNB ) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary F N B Corporatio
Adobe and NVIDIA Expand Collaboration to Speed Agentic Creation
For best results when printing this announcement, please click on link below: Adobe and NVIDIA Expand Collaboration to Speed Agentic Creation Adobe is expanding its collaboration with NVIDIA to optimize its flagship tools including Adobe Photoshop, Premiere, Substance 3D, Frame.io and Brand Concierge, delivering faster
AEye Reports Q2 2026 Results: Full Earnings Call Transcript
AEye (NASDAQ: LIDR ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary AEye Inc reported signifi
Volato Group files 8-K on equity line agreement
Volato Group said it entered into a common stock purchase agreement that would allow it to sell up to $1 billion of newly issued Class A shares to DFU, LLC over 36 months, subject to conditions. The company also agreed to issue commitment securities tied to the arrangement.
Impact BioMedical files 8-K on reverse stock split
Impact BioMedical said it completed a 1-for-12.62 reverse stock split of its common stock on Sept. 23 and began trading on a split-adjusted basis the same day. The filing said the split reduced its issued and outstanding common shares to about 8.6 million.
Liberty Media files 8-K on earnings call notice
Liberty Media said it will host a conference call on Nov. 5 to discuss third-quarter 2026 results and outlook. The filing was made as a Regulation FD disclosure.
Liberty Capital files 8-K on Regulation FD disclosure
Liberty Capital said it filed an 8-K disclosing that it will host a third-quarter earnings conference call on Nov. 5 at 11:15 a.m. ET. The filing says the report and attached press release were furnished under Regulation FD.
Fitch upgrades BlackRock European CLO XV DAC notes
Fitch upgraded the class C, D and E notes of BlackRock European CLO XV DAC and affirmed the other tranches. The actions reflect Fitch's updated CLO criteria and stable portfolio performance.
HubSpot Files 8K - Director, Officer or Compensation Filing >HUBS
HubSpot Inc. (HUBS) filed a Form 8K - Director, Officer or Compensation Filing - with the U.S Securities and Exchange Commission on October 09, 2026. On October 8, 2026, Erika Fisher, the Chief Legal Officer and Corporate Secretary of HubSpot, Inc. (the "Company"), notified the Company of her decision to resign from th
Outlook Therapeutics names Greg DiPasquale chief commercial officer
Outlook Therapeutics appointed Greg DiPasquale chief commercial officer. He will lead commercialization efforts for LYTENAVA as the company prepares a U.S. launch before the end of 2026.
Iron Horse files 8-K on updated merger presentation
Iron Horse Acquisition II said it filed an 8-K and attached an updated investor presentation for its previously announced business combination with Electra Vehicles. The filing also points readers to the related S-4 and proxy materials for the proposed deal.
Quince Therapeutics files 8-K on director changes
Quince Therapeutics said several directors resigned from its board and named four new directors effective Oct. 8, 2026. The filing also disclosed compensation terms for Keith R. Fandrick.
Trinity Capital files 8-K on portfolio activity
Trinity Capital said its third-quarter portfolio activity was disclosed in an SEC Form 8-K. The company also said it plans to release third-quarter 2026 financial statements on November 4 and hold a conference call the same day.
Silver Bow Mining files 8-K on $5 million note
Silver Bow Mining said it entered into a note purchase agreement for a $5.0 million secured promissory note with Ocean Partners UK Limited. The note matures on March 31, 2027 and carries interest at 12-month SOFR plus 6.75%.
FS KKR Capital files 8-K on dividend, earnings call
FS KKR Capital filed an 8-K saying it will host a third-quarter 2026 results call on Nov. 5. The company also declared a regular cash distribution of $0.44 a share and a special cash distribution of $0.20 a share.
Law firm files class action against Beta Bionics
Schall, Brown & Schwartz said it filed a federal securities class action against Beta Bionics and certain executives over claims tied to the company’s iLet insulin pump and FDA reporting. Investors have until Nov. 3, 2026, to seek appointment as lead plaintiff.
Fitch upgrades CVC Cordatus CLO class C and D notes
Fitch upgraded the class C and D notes of CVC Cordatus Loan Fund XXXIII DAC and affirmed the other rated notes. The transaction is still within its reinvestment period and Fitch said performance has remained broadly stable.
Docusign launches PDF Editor for agreement workflow
Docusign said it is adding a PDF Editor to its Intelligent Agreement Management platform. The desktop app will be available to IAM and eSignature customers starting Nov. 2, 2026.
Beyond Air files 8-K on operations and financial condition
Beyond Air said it issued a press release with preliminary, unaudited revenue for the quarter ended September 30, 2026 and reaffirmed its previously issued revenue guidance for calendar 2026 and 2027. The company said its complete quarterly results are expected in November 2026.
H&R REIT files circular for Go Residential transaction vote
H&R Real Estate Investment Trust filed its management information circular and began mailing proxy materials ahead of a special meeting on Nov. 13, 2026, to consider its proposed transaction with GO Residential REIT. The trustees unanimously recommended unitholders vote in favour of the deal.
Scienture Holdings files 8-K on reverse split
Scienture Holdings said it filed a Form 8-K on a 1-for-25 reverse stock split effective Oct. 5. The split was done to help regain compliance with Nasdaq's minimum bid-price requirement.
Vylor Files 8K - Entry Into Definitive Agreement >VYLR
Vylor Inc. (VYLR) filed a Form 8K - Entry Into a Definitive Agreement - with the U.S Securities and Exchange Commission on October 07, 2026. Exchange Offers and Consent Solicitations On October 1, 2026 (the "Settlement Date"), Vylor Inc. ("Vylor") completed its previously announced (i) private offers to exchange (with
Host Digital files Form 8-K on restricted stock grants
Host Digital said it granted 342,864 shares of restricted stock to certain employees, including 74,286 shares to CFO John Ollet, effective Oct. 1. The awards vest in full on Nov. 30, 2026, subject to employment and for-cause conditions.
Rivian files 8-K on $1 billion Volkswagen loan funding
Rivian said it funded the committed $1.0 billion, 10-year term loan facility from Volkswagen Group tied to its joint venture agreement. The company said the proceeds were distributed to Rivian and intended for general corporate purposes.
Charlton Aria Acquisition Files 8K - Entry Into -2
exceptions. Parent has also agreed to engage, and to cause KQC Korea to engage, an independent registered public accounting firm registered with the Public Company Accounting Oversight Board (the "PCAOB") and reasonably acceptable to the Company no later than 15 business days after the date of the Business Combination
TIMELINE — A history of Warner Bros — from old Hollywood to streaming era
(Updates with completion of deal, adds timeline entries) Oct 6 (Reuters) — Paramount Skydance on Tuesday closed its $110 billion acquisition of Warner Bros Discovery, forming an entertainment giant named Skydance and putting CEO David Ellison in charge of one of the world's biggest media companies. The deal brings toge
Stoke Therapeutics: STK-002 data to be presented at AAO 2026
Stoke Therapeutics announced two presentations of data for STK-002, an investigational medicine targeting Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting. The company also provided an update on its Phase 1 OSPREY study, with initial safety and efficacy data an